|Title||The economic burden of Lyme disease and the cost-effectiveness of Lyme disease interventions: A scoping review|
|Publication Type||Journal Article|
|Year of Publication||2019|
|Authors||Mac S, da Silva SR, Sander B|
While Lyme disease (LD) is mostly treatable, misdiagnosed or untreated LD can result in debilitating sequelae and excessive healthcare usage. The objective of this review was to characterize the body of literature on the economic burden of Lyme disease (LD) and the cost-effectiveness of LD interventions, such as antibiotic treatment and vaccination.